Golden
SAGE Therapeutics

SAGE Therapeutics

Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.

Sage Therapeutics is a biopharmaceutical company headquartered in Cambridge, Massachusetts and founded in 2010 by Douglas Covey and Steven Paul. The company develops medicines and therapies to treat disorders of the central nervous system.

Funding

Series A

On October 18, 2011 Sage Therapeutics closed their series A funding round with $35 million in funding from Third Rock Ventures. 

Series B

On October 16, 2013 Sage Therapeutics closed their series B funding round with $20 million in funding from Third Rock Ventures and ARCH Venture Partners. 

Series C

On March 13, 2014 Sage Therapeutics closed their series C funding round with $38 million in funding from Third Rock Ventures, OrbiMed, Foresite Capital, EcoR1 Capital, and ARCH Venture Partners. 

Timeline

Funding rounds

1 Result
Funding round
Funding round
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn

Al Robichaud

Chief Scientific Officer



Amy Schacterle

Senior Vice President, Regulatory Affairs and Quality Assurance



Asha Nayak

Board Member



Deirdre Vitale

Employee



Douglas Covey

Co-Founder



Ed Christian

Employee



Erin Lanciani

Senior Vice President, people and Organizational Strategy



Geno Germano

Board Member



Heinrich Schlieker

Senior Vice President, Technical Operations



James Frates

Board Member



Jeff Jonas

CEO & Member of Board of Directors



Jeff Jonas

Board Member



Jim Doherty

Chief Research Officer



Joseph Kennedy

Employee



Kevin Star

Board Member



Kimi Iguichi

Chief Financial Officer



Meridith Unger

Employee



Michael Cola

Board Member



Mike Ackley

Employee



Mike Cloonan

Chief Business Officer



Steve Kanes

Chief Medical Officer



Steven Paul

Co-Founder & Board Member



Further reading

Title
Author
Link
Type
Date

​Five things you don’t know about Jeff Jonas, CEO of Sage Therapeutics

Don Seinffert

Web



Sage Therapeutics CEO: Have to weigh investor returns but will price postpartum drug 'fairly'

Michelle Fox

News



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References